Ads
related to: pfizer
Search results
Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings - ...
Benzinga· 5 hours agoPfizer's Q1 earnings report expects EPS of 49 cents and $13.09 billion in revenues. Stock has...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 1 day agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
Pfizer and Genmab’s Tivdak wins full FDA approval for cervical cancer
Pharmaceutical Technology via Yahoo Finance· 7 hours agoPfizer and Genmab’s Tivdak (tisotumab vedotin-tftv) has won full approval from the US Food and Drug...
Why I'm Buying This Beaten-Down, High-Yield Dividend Stock Hand Over Fist
Motley Fool via Yahoo Finance· 11 hours agoI owned shares of Pfizer (NYSE: PFE) when the COVID-19 pandemic started. Watching the stock soar...
Moderna Litigation Against BioNTech and Pfizer Stayed Pending IPR | JD Supra
JD Supra· 14 hours agoWe previously reported on the litigation brought by ModernaTX, Inc. and Moderna US, Inc. (collectively, “Moderna”) against BioNTech SE, BioNTech...
5 Top Stocks to Buy in May
Motley Fool via Yahoo Finance· 9 hours agoThat's exactly how these Motley Fool contributors discuss Microsoft (NASDAQ: MSFT), Pfizer (NYSE: PFE), NextEra Energy (NYSE: NEE), Home Depot (NYSE:...
FDA approves Labcorp companion diagnostic for Pfizer gene therapy
Medical Device Network via Yahoo Finance· 9 hours agoThe US Food and Drug Administration (FDA) has approved Labcorp’s nAbCyte Anti-AAVRh74var HB-FE assay...
Pfizer cervical cancer drug gets full approval
Becker’s Hospital Review· 14 hours agoThe FDA has granted full approval for Pfizer's Tivdak (tisotumab vedotin-tftv) to treat cervical cancer in patients whose disease has progressed on or after chemotherapy.
UPDATE 3-GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters via Yahoo Finance· 5 days agoGlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies ...
Pfizer to pay $25.5 mln to settle remaining Effexor XR antitrust claims
Reuters· 23 hours agoPfizer has agreed to pay $25.5 million to resolve claims that its predecessor Wyeth conspired with...
